Cardiac resynchronization therapy in patients with chronic heart failure: Pathophysiology and current experience

American Journal of Cardiovascular Drugs

Volumn 2, Issue 4, 2002, Pages 219-226

  Seidl, Karlheinz ^a   Rameken, Monika ^a   Vater, Margit ^a   Senges, Jochen ^a  

^a Heart Centre   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OXYGEN;

ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECONOMIC ASPECT; EXERCISE TOLERANCE; EXPERIENCE; HEART ARRHYTHMIA; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE SIZE; HEART VENTRICLE CONDUCTION; HEART VENTRICLE CONTRACTION; HEART VENTRICLE FUNCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MITRAL VALVE REGURGITATION; MORBIDITY; MORTALITY; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; QRS COMPLEX; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; SYMPTOMATOLOGY; TIME; TREATMENT FAILURE; TREATMENT INDICATION; WALKING;

EID: 0036386399     PISSN: 11753277     EISSN: None     Source Type: Journal    
DOI: 10.2165/00129784-200202040-00001     Document Type: Article

References (53)

1. Eriksson H. Heart failure: a growing public health problem. J Intern Med 1995; 237: 135-41
2. Ho KKL, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol 1993; 22 Suppl. A: 6A-13A
3. Kannel WB, Belanger AJ. Epidemiology of heart failure. Am Heart J 1991; 121: 951-7
4. Cowie MR, Mostered A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J 1997; 18: 208-25
5. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced LV ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302
6. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the cooperative north Scandinavian enalapril survival study. N Engl J Med 1987; 316: 1429-35
7. Pfeffer MA, Braunwald E, Moye LA, et al. Effects of captopril on mortality and morbidity in patients with LV dysfunction after myocardial infarction: results of the survival and ventricular enlargement study. N Engl J Med 1992; 327: 669-77
8. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 11: 821-7
9. Kober L, Torp Pedersen C, Carlsen JE, et al. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with severe LV dysfunction after myocardial infarction. N Engl J Med 1995; 333: 1670-6
10. The CIBIS II Study Group. The cardiac insufficiency bisoprolol study II (CIBIS II): a randomized trial. Lancet 1999; 353: 9-13
11. The MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). Lancet 1999; 353: 2001-7
12. Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709-17
13. The Digitals Investigative Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-33
14. Hochleitner M, Hortnagl H, Choi-Keung NG, et al. Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol 1990; 66: 198-202
15. Linde C, Gadler F, Edner M, et al. Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am J Cardiol 1995; 75: 919-23
16. Gold MR, Feliciano Z, Gottlieb SS, et al. Dual-chamber pacing with a short atrio-ventricular delay in congestive heart failure: a randomized study. J Am Coll Cardiol 1995; 26: 967-73
17. Brecker SJD, Xiao HB, Sparrow J, et al. Effects of dual-chamber pacing with short atrioventricular delay in dilated cardiomyopathy. Lancet 1992; 340: 1308-12
18. Bakker P, Meiburg H, de Jonge N, et al. Beneficial effects of biventricular pacing in congestive heart failure [abstract]. PACE 1994; 17: 820
19. Cazeau S, Ritter P, Bakdach S, et al. Four chamber pacing in dilated cardiomyopathy. PACE 1994; 17 (11 Pt 2): 1974-9
20. Wilensky RE, Yudelman P, Cohen AL, et al. Serial electrocardiographic changes in idiopathic dilated cardiomyopathy confirmed at necropsy. Am J Cardiol 1998; 62: 276-83
21. Aaronson KD, Schwartz S, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997; 95: 2660-7
22. Xiao HB, Brecker SJD, Gibson DG. Effects of abnormal activation on the time course of the LV pressure pulse in dilated cardiomyopathy. Br Heart J 1992; 68: 403-7
23. Venkateshawar K, Gottpary K, Kreha P, et al., for the VEST investigators. The resting electrocardiogram provides a sensitive and inexpensive marker of prognosis to patients with chronic congestive heart failure [abstract]. J Am Coll Cardiol 1999; 33: 145A
24. Xiao H, Roy C, Pujimoto S, et al. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Am J Cardiol 1996; 57: 163-70
25. Nishimura RA, Hayes DL, Koince Jr DR, et al. Mechanism of hemodynamic improvement by dual-cbamber pacing for active LV dysfunction: an acute doppler and catheterisation study. J Am Coll Cardiol 1995; 25: 281-8
26. Shinbane JS, Chu E, DeMarco T, et al. Evaluation of acute dual-chamber pacing with a range of atrioventricular delays on cardiac performance in refractory heart failure. J Am Coll Cardiol 1997; 30: 1295-300
27. Grines C, Bashore T, Boudoulas H, et al. Functional abnormalities in isolated left bundle branch block: the effect of interventricular asynchrony. Circulation 1989; 79: 845-53
28. Foster AH, Gold MR, McLaughlin JS. Acute hemodynamic effects of atriobiventricular pacing in humans. Ann Thorac Surg 1995; 59: 294-300
29. Xiao Lee C, Gibson D. Effects of left bundle branch block on diastolic function in dilated cardiomyopathy. Br Heart J 1991; 66: 443-7
30. Leclercq C, Cazeau S, Le Breton H, et al. Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol 1998; 32 (7): 1825-31
31. Blanc JJ, Etienne Y, Gilard M, et al. Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. Circulation 1997; 96 (10): 3273-7
32. Auricchio A, Stellbrink C, Sack S, et al. The pacing therapies for congestive heart failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study. Am J Cardiol 1999; 83: 130D-5D
33. Auricchio A, Ding J, Kramer A. Comparison of LV pacing sites for heart failure patients [abstract]. Circulation 1998; 98 (1): 302
34. Auricchio A, Stellbrink C, Block M, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 1999; 99: 2993-3001
35. Kass DS, Chen CH, Curry C, et al. Improved LV mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation 1999; 99: 1567-73
36. Saxon LA, Kerwin WF, Cahalan MK, et al. Acute effects of intraoperative multi-site ventricular pacing on LV function and activation/contraction sequence in patients with depressed ventricular function. J Cardiovasc Electrophysiol 1989; 9: 13-21
37. Butter C, Auricchio A, Stellbrink C, et al. Effects of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation 2001; 104: 3026-9
38. Daubert JC, Ritter P, Le Breton H, et al. Permanent LV pacing with transvenous leads into the coronary veins. Pacing Clin Electrophysiol 1998; 21 (1 Pt 2): 239-45
39. Gras D, Mabo P, Tang T, et al. Multi-site pacing as a Suppl.emental treatment of congestive heart failure: preliminary results of the Medtronic Inc InSync Study. Pacing Clin Electrophysiol 1998; 21 (II): 2249-55
40. Kuhlkamp V. Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy. J Am Coll Cardiol 2002 Mar: 39 (5): 790-7
41. St John Sutton M, Plappert T, Abraham WT. Echocardiographic predictors of functional class changes during cardiac resynchronization therapy: results of the MIRACLE trial. J Am Coll Cardiol 2002; 39 (5 Suppl. A): 107A
42. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344 (12): 873-80
43. Abraham WT, Fisher W, Smith A, et al. Long-term improvement in functional status, quality oflife and exercise capacity with cardiac resynchronization therapy: the MIRCALE trial experience. J Am Coll Cardiol 2002; 39 (5 Suppl. A): 159A
44. Bristow M, Feldman A, Saxon L. Heart failure management using implantable devices for ventricular resynchronization: comparison of medical therapy, pacing and defibrillation in chronic heart failure (COMPANION) tiral. J Cardiac Failure 2000; 6 (3): 276-85
45. The Antiarrhythmics vs Implantable Defibrillators (AVID) Investigators. A comparison of anti arrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-83
46. Guarnieri T, Levine JH, Griffith LS, et al. When 'sudden cardiac death' is not so sudden: lessons learned from the automatic implantable defibrillator. Am Heart J 1988; 115 (1 Pt 1): 205-7
47. Kim SG. Implantable defibrillator therapy; does it really prolong life? How can we prove it. Am J Cardiol 1993; 71: 1213-8
48. Stellbrink C, Auricchio A, Butter C. Pacing therapies in congestive heart failure II study. et al. Am J Cardiol 2000; 86 (9 Suppl. 1): K138-43
49. Stellbrink C, Auricchio A, Diem B, et al. Potential benefit of biventricular pacing in patients with congestive heart failure and ventricular tachyarrhythmia. Am J Cardiol 1999; 83: 143D-50D
50. Higgins SL, Yong P, Sheck D, et al. Biventricular pacing diminishes the need for implantable cardioverter defibrillator therapy. J Am Coll Cardiol 2000; 36 (3): 824-7
51. Walker S, Levy TM, Coats AJS, et al. Be-ventricular pacing in congestive cardiac failure: current experience and future directions. Eur Heart J 2000; 21: 884-9
52. Hill MRS, Conners SP, Hassa A, et al. Coronary venous vasculature in congestive heart failure patients: opportunities for LV pacing [abstract]. Europace 2000; 1: D238
53. Sogaard P, Kin Y, Jensen HK, et al. Impact of electrode positioning in biventricular pacing on LV synchrony and function: a 3-dimensional transthoracic second harmonic echocardiographic study with tissue Doppler imaging [abstract]. Europace 2000; 1: D238